Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000728889-09-000117
Filing Date
2009-01-26
Accepted
2009-01-26 15:33:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 1 TO SCHEDULE 13G schedule13g.htm SC 13G/A 46313
  Complete submission text file 0000728889-09-000117.txt   48718
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 09545470
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6803 SOUTH TUCSON WAY N/A CENTENNIAL CO 80112-3924
Business Address 6803 SOUTH TUCSON WAY N/A CENTENNIAL CO 80112-3924 303-768-3200
OPPENHEIMER FUNDS INC (Filed by) CIK: 0000728889 (see all company filings)

EIN.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000